CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion | +2,700 | 25,063 | ||
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion | +10,617 | 35,680 | ||
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Shares withheld for taxes | −5,330 | $2.17 | $12K | 30,350 |
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion · Restricted Stock Units | −5,400 | 0 | ||
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion · Restricted Stock Units | −2,700 | 2,700 | ||
| 2023-02-28 | Alexander Kristen VP, Finance and Accounting | Exercise or conversion · Restricted Stock Units | −10,617 | 21,233 | ||
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion | +14,833 | 36,700 | ||
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion | +5,286 | 41,986 | ||
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion | +22,963 | 64,949 | ||
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Shares withheld for taxes | −11,813 | $2.17 | $26K | 53,136 |
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −14,833 | 0 | ||
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −5,286 | 5,287 | ||
| 2023-02-28 | Seth Kiernan VP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −22,963 | 45,927 | ||
| 2023-02-28 | McDermott Wendy VP, Human Resources | Exercise or conversion | +18,943 | 18,943 | ||
| 2023-02-28 | McDermott Wendy VP, Human Resources | Shares withheld for taxes | −6,465 | $2.17 | $14K | 12,478 |
| 2023-02-28 | McDermott Wendy VP, Human Resources | Exercise or conversion · Restricted Stock Units | −18,943 | 37,887 | ||
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Exercise or conversion | +23,300 | 198,889 | ||
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Exercise or conversion | +8,976 | 207,865 | ||
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Exercise or conversion | +25,667 | 233,532 | ||
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Shares withheld for taxes | −20,946 | $2.17 | $45K | 212,586 |
Page 18 of 27 · 540 trades